Pipeline
Program |
---|
Program |
Discovery |
Lead candidate identification |
IND-enabling studies |
Phases 1-3 |
||||
---|---|---|---|---|---|---|---|---|
NTX-250 Target Undisclosed Modality Multimodal RNA therapeutic Indication HPV-driven tumors |
||||||||
|
||||||||
NTX-565 Target Undisclosed Modality Patient-specific multimodal RNA therapeutic Indication T cell lymphoma |
||||||||
|
||||||||
NTX-470 Target Undisclosed Modality Multimodal RNA therapeutic Indication Genitourinary tumors |
||||||||
|